As a member of the National Coalition of Autoimmune Patients Groups (NCAPG), a coalition founded by the American Autoimmune Related Diseases Association (AARDA), the Celiac Disease Foundation signed onto the proposed rule comments from I Am Essential that would dramatically change the regulations that implement Section 1557, the anti-discrimination provision of the Affordable Care Act. The…

All over the country, parents are getting ready to send their children back to school. Our children, Alexander Solomon, Amanda Solomon, and Draya Ramer, have celiac disease. Returning to school presents special challenges every year…challenges that are magnified if a child is starting a new school or even moving to a new classroom. That is why we are…

On June 3, 2019, Marilyn G. Geller, CEO of the Celiac Disease Foundation, submitted Outside Witness Testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies.

      Outside Witness Testimony – Fiscal Year 2020 Appropriations Prepared By Marilyn G. Geller, CEO, Celiac Disease Foundation Prepared for the Subcommittee on Labor, Health and Human Services, Education and Related Agencies Committee on Appropriations United States Senate June 3, 2019 ______________________________ Chairman Blunt, Ranking Member Murray, and distinguished Members of the Subcommittee,…

Representatives Tim Ryan (D-OH) and Tom Cole (R-OK) introduced H.R. 2074, the Gluten in Medicine Disclosure Act of 2019. The bill intends to make it easier to identify gluten in prescription medications.